FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048897850> ?p ?o ?g. }

• W3048897850 endingPage "e000927" @default.
• W3048897850 startingPage "e000927" @default.
• W3048897850 abstract "Background Reactivation of hepatitis B virus (HBV) infection is a well-recognized complication in patients with chronic or resolved HBV infection undergoing anticancer therapy. There is a risk of HBV reactivation after infusion of chimeric antigen receptor (CAR) T cells for patients with refractory/relapsed (R/R) multiple myeloma (MM). Methods We administered B cell maturation antigen (BCMA) CAR-T cell by infusion to nine patients with R/R MM with chronic or resolved HBV infection. Patient serum was analyzed to determine the expression of five components of HBV and the copy number of HBV DNA. HBV reactivation was defined if a patient re-exhibited hepatitis B surface antigen (HBsAg) or HBV DNA regrowth after CAR-T therapy. Results In one patient who was HBsAg-positive, no HBV reactivation was observed during the follow-up period of 9.8 months after administration of anti-HBV drugs before and after CAR-T therapy. Among eight patients with MM who had resolved HBV infection, two patients administered prophylactic anti-HBV drugs did not exhibit HBV reactivation. Of the six patients who did not use prophylactic antiviral drugs, five did not exhibit HBV reactivation, while one showed recurrence of HBsAg without detection of HBV DNA or damage to liver function. The best objective response rate was 100%, and the progression-free survival (PFS) at 12 months was of 88.89% (median PFS was not observed). Conclusions These findings showed that BCMA CAR-T cell therapy could be used in patients with R/R MM with chronic or resolved HBV infection and that antiviral drugs should be administered in these patients during CAR-T cell therapy." @default.
• W3048897850 created "2020-08-18" @default.
• W3048897850 creator A5000406804 @default.
• W3048897850 creator A5000927257 @default.
• W3048897850 creator A5004139292 @default.
• W3048897850 creator A5008400279 @default.
• W3048897850 creator A5009514201 @default.
• W3048897850 creator A5010355527 @default.
• W3048897850 creator A5014270790 @default.
• W3048897850 creator A5023342846 @default.
• W3048897850 creator A5031142169 @default.
• W3048897850 creator A5031523854 @default.
• W3048897850 creator A5050450526 @default.
• W3048897850 creator A5052368006 @default.
• W3048897850 creator A5066054740 @default.
• W3048897850 creator A5075372820 @default.
• W3048897850 date "2020-08-01" @default.
• W3048897850 modified "2023-10-14" @default.
• W3048897850 title "Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus" @default.
• W3048897850 cites W1799522345 @default.
• W3048897850 cites W1967577450 @default.
• W3048897850 cites W1971850723 @default.
• W3048897850 cites W1984724288 @default.
• W3048897850 cites W1988234424 @default.
• W3048897850 cites W1995985267 @default.
• W3048897850 cites W1997047331 @default.
• W3048897850 cites W2020298011 @default.
• W3048897850 cites W2025722002 @default.
• W3048897850 cites W2051055769 @default.
• W3048897850 cites W2056062485 @default.
• W3048897850 cites W2059800699 @default.
• W3048897850 cites W2082708772 @default.
• W3048897850 cites W2088466832 @default.
• W3048897850 cites W2095058829 @default.
• W3048897850 cites W2096966773 @default.
• W3048897850 cites W2101867956 @default.
• W3048897850 cites W2105403730 @default.
• W3048897850 cites W2140579395 @default.
• W3048897850 cites W2149704151 @default.
• W3048897850 cites W2161758234 @default.
• W3048897850 cites W2327882300 @default.
• W3048897850 cites W2471662063 @default.
• W3048897850 cites W2486629951 @default.
• W3048897850 cites W2595092734 @default.
• W3048897850 cites W2755114342 @default.
• W3048897850 cites W2770457793 @default.
• W3048897850 cites W2775001520 @default.
• W3048897850 cites W2781388087 @default.
• W3048897850 cites W2807637103 @default.
• W3048897850 cites W2906581363 @default.
• W3048897850 cites W2938308258 @default.
• W3048897850 cites W2943335541 @default.
• W3048897850 cites W2946307588 @default.
• W3048897850 cites W2991612669 @default.
• W3048897850 cites W4252175385 @default.
• W3048897850 doi "https://doi.org/10.1136/jitc-2020-000927" @default.
• W3048897850 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7430488" @default.
• W3048897850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32792360" @default.
• W3048897850 hasPublicationYear "2020" @default.
• W3048897850 type Work @default.
• W3048897850 sameAs 3048897850 @default.
• W3048897850 citedByCount "21" @default.
• W3048897850 countsByYear W30488978502021 @default.
• W3048897850 countsByYear W30488978502022 @default.
• W3048897850 countsByYear W30488978502023 @default.
• W3048897850 crossrefType "journal-article" @default.
• W3048897850 hasAuthorship W3048897850A5000406804 @default.
• W3048897850 hasAuthorship W3048897850A5000927257 @default.
• W3048897850 hasAuthorship W3048897850A5004139292 @default.
• W3048897850 hasAuthorship W3048897850A5008400279 @default.
• W3048897850 hasAuthorship W3048897850A5009514201 @default.
• W3048897850 hasAuthorship W3048897850A5010355527 @default.
• W3048897850 hasAuthorship W3048897850A5014270790 @default.
• W3048897850 hasAuthorship W3048897850A5023342846 @default.
• W3048897850 hasAuthorship W3048897850A5031142169 @default.
• W3048897850 hasAuthorship W3048897850A5031523854 @default.
• W3048897850 hasAuthorship W3048897850A5050450526 @default.
• W3048897850 hasAuthorship W3048897850A5052368006 @default.
• W3048897850 hasAuthorship W3048897850A5066054740 @default.
• W3048897850 hasAuthorship W3048897850A5075372820 @default.
• W3048897850 hasBestOaLocation W30488978501 @default.
• W3048897850 hasConcept C121608353 @default.
• W3048897850 hasConcept C126322002 @default.
• W3048897850 hasConcept C147483822 @default.
• W3048897850 hasConcept C159047783 @default.
• W3048897850 hasConcept C203014093 @default.
• W3048897850 hasConcept C2522874641 @default.
• W3048897850 hasConcept C2777382497 @default.
• W3048897850 hasConcept C2777410769 @default.
• W3048897850 hasConcept C2777701055 @default.
• W3048897850 hasConcept C2780593183 @default.
• W3048897850 hasConcept C3875195 @default.
• W3048897850 hasConcept C71924100 @default.
• W3048897850 hasConcept C90924648 @default.
• W3048897850 hasConceptScore W3048897850C121608353 @default.
• W3048897850 hasConceptScore W3048897850C126322002 @default.
• W3048897850 hasConceptScore W3048897850C147483822 @default.
• W3048897850 hasConceptScore W3048897850C159047783 @default.

• next